CTLA4 and cancer: Among these, CXCR2P1 has been speculated to be related to immune checkpoints PD-1, PD-L1, and CTLA4, which are crucial for successful cancer immunotherapy that contribute to the immune response [40, 41], but there is still a lack of direct evidence.